Research Article

The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization

Table 4

Univariate and multivariate regression analyses for progression-free survival before propensity score matching.

CharacteristicsUnivariable analysisMultivariable analysis
HR (95% CI) valueHR (95% CI) value

Age (years)0.994 (0.981, 1.008)0.402
AST1.002 (0.997, 1.007)0.410
ALT1.000 (0.993, 1.007)0.926
Bilirubin1.012 (0.998, 1.026)0.103
Albumin0.981 (0.959, 1.003)0.093
NLR1.026 (0.980, 1.074)0.276
PLR1.000 (0.999, 1.002)0.757
Maximal tumor size (cm)1.068 (1.028, 1.109)0.0011.072 (1.032, 1.115)<0.001

Gender
MaleRef0.789
Female1.067 (0.665, 1.711)

Smoking
YesRef0.357
No1.133 (0.869, 1.478)

HBV infection
YesRef0.803
No1.044 (0.746, 1.460)

HCV infection
YesRef0.872
No0.989 (0.929, 1.102)

Cirrhosis
YesRef0.076
No0.777 (0.589, 1.026)

Ascites
YesRef0.109
No0.719 (0.481, 1.076)

TACE session
OnceRef<0.001Ref<0.001
Multiple times0.413 (0.279, 0.610)0.439 (0.296, 0.652)

Tumor number
1Ref0.135
≥21.243 (0.935, 1.653)

BCLC stage
ARef
B1.280 (0.626, 2.616)0.499
C1.503 (0.723, 3.126)0.275

AFP level
<200Ref0.729
≥2001.050 (0.795, 1.388)

Child-Pugh
ARef0.523
B1.104 (0.815, 1.495)

ECOG score
0Ref0.215
11.192 (0.903, 1.573)

Alcohol
AbstinenceRef0.007Ref0.010
Consumption1.452 (1.109, 1.900)1.434 (1.091, 1.886)